• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Dr. Keith Baker - Designer (Dirty) Drugs
Dr. Keith Baker - Designer (Dirty) Drugs

... then allowed to become legal because the DEA was unable to justify permanent scheduling ...
Antibiotic PK/PD
Antibiotic PK/PD

... Clinical Pharmacy Specialist King Hussein Cancer Center Amman, Jordan ...
Prescribing in the Elderly - Benton Franklin County Medical Society
Prescribing in the Elderly - Benton Franklin County Medical Society

... – almost 500 million people worldwide had reached or exceeded age 65 ...
Document
Document

... Must figure reimbursement strategies as drug development proceeds. This involves working with CMS and individual insurance companies Must explain to patient groups the rationale for cost of the product if high. Cost may by necessity be high Some EU member states very conservative in reimbursement Re ...
Psychiatric Drugs
Psychiatric Drugs

... marketing to consumers and public-awareness campaigns about depression. 3. The Rise in managed care has also contributed to the increase in use of medication, which may be less costly and time-consuming than psychotherapy. Managed care also has placed more emphasis on primary-care physicians, who ma ...
Internal Medicine Morning Report
Internal Medicine Morning Report

... drugs absorption, distribution, metabolism, excretion or clinical effect • Additionally, newly introduced medications, and medications with new indications may have multiple pharmacologic effects ...
Part 1
Part 1

... retention, constipation, and dry mouth ...
About ATODA
About ATODA

... Know your tolerance - be aware when it might be lower (e.g. not using for a while, being in prison, etc.) and use less if not sure Avoid mixing drugs - mixing opioid drugs with other depressants (benzodiazepines, alcohol, other opioids) Take care of your health - eat well, drink plenty of water and ...
Drug Discovery and Development
Drug Discovery and Development

... • Under this law, companies who develop such a drug are entitled to market it without competition for seven years. • This is considered a significant benefit, since the standards for patent protection are much more stringent. ...
Tuberculosis Chemotherapy
Tuberculosis Chemotherapy

... Distribution – it penetrates in all tissues , tubercular cavities, placenta. Adequate CSF levels are reached if meninges are inflammed. It is significantly protein bound. ...
Toxicology Power Point
Toxicology Power Point

... • Many insect and mammalian poisons are particularly dangerous because they are not host specific and are designed specifically to kill a wide range of organisms • Because of their widespread agricultural use as well as availability to consumers, accidental exposure by direct exposure to the pestici ...
Polypharmacy - Dr. Bill Dalziel
Polypharmacy - Dr. Bill Dalziel

... 30% of hospital admissions linked to ADR in US ( Hanlon et al. JAGS 1997) After discharge from TOH, 23% had at least one ADR ( Forster et al. CMAJ 2004) ADR in the older person linked to depression, constipation, falls, immobility, confusion, and hip fractures… (Bootman et al. AIM 1997) ...
Drugs
Drugs

... container ...
Human Research Involving Drugs and Biologics  1.0 Purpose:
Human Research Involving Drugs and Biologics 1.0 Purpose:

... 4.2 Investigational new drug: a new drug or biological drug that is used in a clinical investigation. The term also includes a biological product that is used in vitro for diagnostic purposes. The terms "investigational drug" and "investigational new drug" are synonymous. 4.3 Biologics License Appli ...
Pharmaceutical Technology
Pharmaceutical Technology

... of the liquid solutions that can be measured accurately; this allows a range of different doses to be easily administered • Oral solutions are easily swallowed and are beneficial for patients for whom swallowing may be difficult, e.g. children and older people. • Solutions are easier to manufacture ...
Pharmacokinetic processes: liberation
Pharmacokinetic processes: liberation

... Pharmacokinetic processes: liberation Drug delivery systems Drug delivery systems (also called dosage forms) are necessary to enable the effective, safe and reliable use of medicinal drugs. Most drugs are formulated into tablets or other forms of medicine. A formulation is a mixture, made to a speci ...
Ch. 6-Basic Pharmacology - NAC / CNA Certification Spokane
Ch. 6-Basic Pharmacology - NAC / CNA Certification Spokane

... • Some people react differently to same drug at the same dosages – Factors that affect a person’s response to a drug: ...
general pharmacology
general pharmacology

... Exocytosis: expulsion of membrane-bound particles. Phagocytosis occurs for high molecular weight Drugs or highly lipid insoluble drugs. ...
Tuberculosis
Tuberculosis

... Dr Sajith.VS ...
“Breakthrough” drugs and growth in expenditure on prescription
“Breakthrough” drugs and growth in expenditure on prescription

The War on Drugs
The War on Drugs

... “Not only does it not increase the amount of drugs used, but people who have been trained are more safety conscious and are at less risk of an overdose,” says Buxton. 2016 naloxone becomes over the counter “Take home” naloxone: what does the evidence base tell us? (2015): May reduce overdose deaths ...
clinical pharmacology of drugs affecting the nervous system
clinical pharmacology of drugs affecting the nervous system

... • Regular use of amphetamines induces tolerance to some effects, which means that more and more of the drug is required to produce the desired effects. Tolerance does not develop to all effects at the same rate, however; indeed, there may be increased sensitivity to some of them. • Chronic users may ...
United States Food and Drug Administration Increases Enforcement
United States Food and Drug Administration Increases Enforcement

... United States Food and Drug Administration Increases Enforcement Efforts Against Common Cough, Cold and Allergy Drugs, Warns FDAImports.com In early March 2011 , the U.S. Food and Drug Administration (“FDA”) significantly increased its enforcement rhetoric against all companies manufacturing, import ...
Synergistic stabilization of BCS Class II drug
Synergistic stabilization of BCS Class II drug

... hydroxypropyl cellulose (HPC) with/without sodium dodecyl sulfate (SDS) via a stirred media mill. Laser diffraction, scanning electron microscopy, thermal analysis, rheometry and electrophoresis were used to evaluate the breakage kinetics, storage stability, electrostatic repulsion and stabilizer ad ...
Depressants
Depressants

... - tolerance and addiction develop rapidly - lethal dose is low and nearer to drug’s ED compared with other drugs, so potential for overdose is high ...
< 1 ... 135 136 137 138 139 140 141 142 143 ... 161 >

Orphan drug

An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.In the US and EU it is easier to gain marketing approval for an orphan drug, and there may be other financial incentives, such as extended exclusivity periods, all intended to encourage the development of drugs which might otherwise lack a sufficient profit motive. The assignment of orphan status to a disease and to any drugs developed to treat it is a matter of public policy in many countries, and has resulted in medical breakthroughs that may not have otherwise been achieved due to the economics of drug research and development.According to Thomson Reuters in their 2012 publication ""The Economic Power of Orphan Drugs"", there has been increased investing in orphan drug Research and Development partly due to the U. S. Orphan Drug Act (ODA) 1983 and similar Acts in other regions of the world and also driven by ""high-profile philanthropic funding."" The period between 2001 to 2011 was the ""most productive period in the history of orphan drug development, in terms of average annual orphan drug designations and orphan drug approvals."" For the same decade the compound annual growth rate (CAGR) of the orphan drugs was an ""impressive 25.8 percent, compared to only 20.1 percent for a matched control group of non-orphan drugs."" By 2012 the market for orphan drugs was worth USD$637 million compared to the USD$638 million matched control group of non-orphan drugs, Thomson Reuters.By 2012, ""the revenue-generating potential of orphan drugs [was] as great as for non-orphan drugs, even though patient populations for rare diseases are significantly smaller. Moreover, we suggest that orphan drugs have greater profitability when considered in the full context of developmental drivers including government financial incentives, smaller clinical trial sizes, shorter clinical trial times and higher rates of regulatory success.""
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report